Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Acurx Pharmaceuticals, Inc. (ACXP) had Pre-Tax Income of $-2.78M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-2.78M |
|
-- |
|
-- |
|
$2.78M |
|
$-2.78M |
|
-- |
|
|
Pre-Tax Income |
$-2.78M |
$-2.78M |
|
$-2.78M |
|
$-2.78M |
|
$-2.78M |
|
$-2.78M |
|
$-2.78M |
|
$-2.78M |
|
16.16M |
|
16.16M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$3.86M |
|
-- |
|
-- |
|
$3.86M |
|
$3.24M |
|
-- |
|
-- |
|
$3.24M |
|
$0.62M |
|
$0.62M |
|
$0.62M |
|
17.03M |
|
| Cash Flow Statement Financials | |
$-10.38M |
|
-- |
|
$6.62M |
|
$7.47M |
|
$3.71M |
|
$-3.77M |
|
$3.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.38M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-452.24% |
|
-452.23% |
|
-72.11% |
|
-452.23% |
|
$0.04 |
|
$-0.64 |
|
$-0.64 |
|